Cite

HARVARD Citation

    Chaftari, A. et al. (n.d.). 291Efficacy and safety of telavancin in the treatment ofram-positive bloodstream infections in cancer patients. Open forum infectious diseases. p. S121. [Online]. 
  
Back to record